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Immunization with attenuated Plasmodium sporozoites or viral vectored vaccines can induce protective CD8 T cells that can
find and eliminate liver-stage malaria parasites. A key question is whether CD8 T cells must recognize and eliminate each para-
site in the liver or whether bystander killing can occur. To test this, we transferred antigen-specific effector CD8 T cells to mice
that were then coinfected with two Plasmodium berghei strains, only one of which could be recognized directly by the trans-
ferred T cells. We found that the noncognate parasites developed normally in these mice, demonstrating that bystander killing of
parasites does not occur during the CD8 T cell response to malaria parasites. Rather, elimination of infected parasites is likely
mediated by direct recognition of infected hepatocytes by antigen-specific CD8 T cells.
Immunization with irradiated sporozoites induces a CD8 T cellresponse that can protect against live parasite challenge (1–3).
Despite the well-established role of CD8 T cells in immunity, the
mechanism by which they find and eliminate parasites remains
unclear. One key outstanding question is whether CD8 T cells
kill via contact-mediated processes following direct recognition of
the infected hepatocyte or whether they may also kill bystander
parasites at a distance via the production of inflammatory medi-
ators. This is a critical issue, as bystander killing processes would
potentially allow immunosurveillance by a smaller number of
CD8 T cells. If, however, killing takes place only after recognition
of each individual infected hepatocyte by cognate CD8 T cells, a
much larger number of cells would be required for protection.
A variety of studies have attempted to determine which are the
critical effector molecules for parasite elimination. Collectively,
these data conclude that a range of redundant mechanisms oper-
ate, including the secretion of tumor necrosis factor alpha
(TNF-) and gamma interferon (IFN-) (2, 4, 5), both of which
may be produced by malaria-specific CD8 T cells (6). On the
other hand, there is only limited evidence for the use of the perfo-
rin-granzyme pathway in the elimination of Plasmodium parasites
by CD8 T cells (6, 7). The importance of secreted cytokines in
parasite elimination has led to the suggestion that these may
spread though the liver and mediate the killing of bystander par-
asites (8, 9). Such bystander killing could potentially occur after
the recognition of antigen presented by either an infected hepato-
cyte or an uninfected antigen-presenting cell. Nonetheless, a vari-
ety of lines of evidence support the notion that CD8 T cell killing
occurs following cognate CD8 T cell-hepatocyte interactions.
Recent independent in vivo imaging studies observed clustering of
CD8 T cells around infected hepatocytes that led to the eventual
killing of the parasites (10, 11). Moreover, several in vitro and in
vivo studies suggest that the infected cells themselves are able to
present antigen directly to effector CD8 T cells (12–15). How-
ever, it is possible that in addition to the elimination of cognate
parasites, bystander parasites may also be eliminated during this
potent CD8 T cell response.
To test whether bystander killing can occur following sporozo-
ite challenge, we transferred antigen-specific effector CD8 T cells
to mice that were then coinfected with two Plasmodium berghei
strains, only one of which could be recognized directly by the
transferred T cells. Using this strategy, we demonstrated that by-
stander killing of parasites does not occur during the CD8 T cell
response to malaria parasites. Rather, we found that CD8 T cell
activity is restricted to the immediate microenvironment of the
infected cell and thus that protection depends upon each parasite
being found and eliminated by cognate CD8 T cells.
MATERIALS AND METHODS
Mice and parasites. C57BL/6 and B6-Ly5.2 mice were obtained from the
National Cancer Institute (Frederick, MD). OT-I mice (16) were obtained
from David Sacks (NIAID, Bethesda, MD). P. berghei-CS5M was previ-
ously generated in our laboratory (15). P. berghei-ConF (17) was obtained
from Rogerio Amino and Robert Menard (Institut Pasteur, Paris, France),
and P. berghei-mCherry (18) was kindly provided by Volker Heussler
(University of Bern). All experimental procedures on animals were ap-
proved by the Institutional Animal Care and Use Committee of the Johns
Hopkins University.
Generation of P. berghei CS5M-mCherry parasites. P. berghei CS5M-
mCherry parasites were generated by crossing two previously generated
parasite lines: P. berghei CS5M (15) and P. berghei-mCherry (18). Briefly,
mice were coinfected with P. berghei CS5M and P. berghei-mCherry at a
ratio of 10:1. Anopheles stephensi mosquitoes were allowed to feed on the
mice, and subsequently, sporozoites dissected from these mosquitoes
were used to infect naive animals. Parasites expressing the mCherry trans-
gene were sorted from the blood of these mice by use of a FACSAria cell
sorter and used to infect mice. Subsequently, the mCherry-positive prog-
eny were cloned and the clones screened for the insertion of the CS5M
transgene by PCR as described previously (15).
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Preparation of OT-I effector cells. CD45.1 OT-I CD8 transgenic
cells specific for the SIINFEKL epitope were adoptively transferred into
C57BL/6 mice (1  106 cells per mouse) before immunization with 5 
106 PFU per mouse of vaccinia virus-OVA. Seven to 10 days later, the
spleens were harvested and lymphocytes were prepared by passage over a
Lymphoprep-M gradient (Cedarlane Laboratories). The number of
CD8 CD45.1 effector cells was then quantified by flow cytometry and
the volume normalized such that 5  106 effector cells were transferred
per mouse.
In vivo imaging and analysis. The livers of anesthetized C57BL/6
mice were exposed by surgery as previously described (19). For each
mouse, a tile scan of the entire area of the liver was acquired by laser
confocal spinning disk microscopy (3i), using a 10 air objective (Zeiss).
Tile scans were formed into a montage and thresholded in order to facil-
itate counting of the different fluorescent parasites. For calculation of the
number of parasites/mm3, we determined that the depth of field of the tile
scan was 50 m based on the objective used.
Flow cytometry. P. berghei CS5M-mCherry and P. berghei-ConF para-
sitemias were quantified by flow cytometry. Five microliters of blood was
taken from the tails of infected mice and diluted in 995 l Hanks balanced
salt solution (HBSS) prior to analysis by flow cytometry using an LSR-II
instrument (BD Biosciences) equipped with a 561-nm green laser which
enabled the acquisition of mCherry fluorescence in the phycoerythrin
(PE)-Texas Red channel. Green fluorescent protein (GFP) fluorescence
was acquired in the fluorescein isothiocyanate (FITC) channel.
Analysis of parasite loads in livers by reverse transcription-PCR
(RT-PCR). Quantification of liver-stage parasites was performed as pre-
viously described (20). Briefly, 42 h after challenge with 1  104 P. berghei
sporozoites, livers were excised and parasite loads were determined by
quantitative PCR analysis of P. berghei 18S rRNA by use of SYBR green
(Applied Biosystems).
RESULTS
Experimental design and development of P. berghei CS5M-
mCherry parasites. To determine whether CD8 T cells can kill
bystander parasites as well as cognate parasites, we developed an
experimental strategy in which we infected mice with 2 related P.
berghei parasites expressing different fluorescent markers. One
fluorescent strain would express a model CD8 T cell epitope that
could be the target of protective antigen-specific effector cells,
while the other fluorescent strain would not carry this epitope and
therefore could not be recognized directly by the antigen-specific
CD8 T cells. We reasoned that if bystander killing took place,
transfer of activated antigen-specific CD8 T cells would result in
the elimination of both the cognate and noncognate parasites. On
the other hand, if CD8 T cells killed via localized effector mech-
anisms, the development of the noncognate parasites would be
unaffected by the transfer of the activated CD8 T cells (Fig. 1A).
To develop fluorescent P. berghei parasites expressing a model
antigen, we crossed previously generated P. berghei-mCherry par-
asites (18) with P. berghei CS5M (15) to create a line of parasites
which we designated P. berghei CS5M-mCherry (CS5M-mCherry)
(see Materials and Methods). P. berghei CS5M parasites express the
SIINFEKL epitope from ovalbumin in place of the endogenous
SYIPSAEKI epitope in the circumsporozoite (CS) protein and are
therefore efficiently eliminated by effector OT-I cells which rec-
ognize the SIINFEKL epitope. As expected, we found that ef-
fector OT-I cells were also able to kill parasites in mice infected
with CS5M-mCherry parasites. For control parasites, we used P.
berghei-ConF (CSWT-GFP), which carries the endogenous CS
protein and expresses GFP under the control of the HSP70 pro-
moter (17). Crucially, effector OT-I cells were unable to elimi-
nate parasites from mice infected with CSWT-GFP parasites
alone (Fig. 1B).
Antigen-specific effector CD8 T cells do not kill bystander
liver-stage parasites. To test whether antigen-specific effector
cells can kill bystander parasites as well as those expressing their
cognate epitope, 5  106 effector OT-I T cells were transferred to
mice that were subsequently coinfected with equal numbers of
CSWT-GFP and CS5M-mCherry parasites. Control mice which had
not received effector OT-I T cells were also coinfected with the 2
parasite lines. At 24 to 26 h postinfection, the mice were anesthe-
tized and prepared for intravital imaging as described previously
(19). Using spinning disk confocal microscopy, we were able to
observe numerous CSWT-GFP and CS5M-mCherry parasites in the
livers of control mice. Conversely, in the presence of OT-I cells,
only CSWT-GFP parasites could be seen, though some red debris
was also observed (Fig. 2A), suggesting that the red (cognate) par-
asites, but not the green (noncognate) parasites, had been elimi-
nated.
To quantify the numbers of CS5M-mCherry and CSWT-GFP
parasites in mice with and without effector OT-I cells, tile scans of
the entire exposed area of the liver were taken and the numbers of
CS5M-mCherry and CSWT-GFP parasites counted. While CS5M
parasites were undetectable in mice that received OT-I cells, the
number of CSWT-GFP parasites in the liver was not significantly
affected by the ongoing killing of CS5M-mCherry parasites by ef-
fector OT-I cells, suggesting that bystander killing was not taking
place (Fig. 2B).
FIG 1 Development of P. berghei CS5M-mCherry parasites. (A) General ex-
perimental design for bystander killing experiments. (B) RT-PCR quantifica-
tion of the number of parasites in the liver at 42 h postinfection, with or
without transfer of 3  106 effector OT-I cells prior to infection. P. berghei 18S
rRNA was measured 42 h after infection with either 1  104 CS5M-mCherry
parasites (i) or 1  104 CSWT-GFP parasites (ii). Data are based on 5 mice per
group and were analyzed by 2-tailed Student’s t test. AU, arbitrary units.
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Development of bystander parasites to the asexual blood
stage is complete. In the previous experiment, we were unable to
detect any bystander killing of CSWT-GFP parasites at 24 to 26 h
postinfection. However, it is possible that the continuing presence
of cytokines such as IFN- and TNF- produced during the effec-
tor phase of the CD8 T cell response may prevent the complete
development of bystander CSWT-GFP parasites. To test this, we
transferred effector OT-I cells to mice that then received CS5M-
mCherry and CSWT-GFP sporozoites at a ratio of 4:1. A ratio of 4:1
CS5M-mCherry to CSWT-GFP parasites was used to increase the
likelihood of observing bystander killing. Control groups of mice
received either CS5M-mCherry and CSWT-GFP parasites without
any activated OT-I cells or effector OT-I cells and CSWT-GFP par-
asites alone.
In mice that did not receive OT-I cells, both asexual CS5M-
mCherry and CSWT-GFP parasites could readily be detected by
flow cytometry on day 4 postinfection (Fig. 3A, panel i, and B).
Conversely, in coinfected mice that received OT-I cells, only
CSWT-GFP parasites could be seen from day 4 onwards (Fig. 3A,
panel ii, and B). Importantly, the number of CSWT-GFP parasites
FIG 2 Antigen-specific effector CD8 T cells do not kill bystander liver-stage parasites. (A) Representative confocal images of the livers of mice 24 to 26 h after
coinfection with 5  105 (each) CS5M-mCherry and CSWT-GFP parasites. Different groups of mice either received 5  106 effector OT-I T cells or did not receive
effector cells. (B) Quantification of the numbers of parasites seen in the liver after coinfection with 1  105 (each) CS5M-mCherry and CSWT-GFP parasites, with
or without adoptive transfer of 5  106 effector OT-I cells. Data are based on tile scans of the entire exposed area of the liver for 3 mice per group and are
representative of 2 similar experiments.
FIG 3 Complete liver-stage development of bystander parasites. (A) Representative flow cytometry plots of blood-stage CSWT-GFP and CS5M-mCherry parasites
at day 6 post-sporozoite immunization under various conditions, i.e., coinfection of mice with 4  104 CS5M-mCherry and 1  104 CSWT-GFP parasites (i),
coinfection of mice with 4  104 CS5M-mCherry and 1  104 CSWT-GFP parasites following adoptive transfer of 5  106 effector OT-I T cells (ii), and infection
of mice with 1  104 CSWT-GFP parasites following adoptive transfer of 5  106 effector OT-I cells (iii). (B) Quantification of CS5M-mCherry (i) and CSWT-GFP
(ii) daily parasitemias in the three groups of mice shown in panel A. Parasitemia was analyzed by Student’s t test, using the group that received both parasite strains
and effector OT-I cells as the reference (**, P  0.01; ***, P  0.001). Data are based on 5 to 7 mice per group from one of two similar experiments.
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in coinfected mice that received OT-I cells was statistically indis-
tinguishable (by unpaired Student’s t test) from the number in
control mice that received just CSWT-GFP and effector OT-I cells,
i.e., in the absence of an ongoing cognate CD8 T cell response
(Fig. 3A, panel iii, and B). Interestingly, the number of blood-stage
CSWT-GFP parasites was smaller in the presence of a blood-stage
CS5M-mCherry infection, presumably due to competition be-
tween the two parasite lines (Fig. 3B). Together, these data exclude
the possibility of cytokines killing by a delayed action on liver-
stage parasites and further support the finding that Plasmodium-
specific T cells do not induce bystander killing.
DISCUSSION
In these experiments, we found that CD8 T cells can eliminate
parasites only by locally acting effector functions following cog-
nate interactions with antigen. The most parsimonious explana-
tion for our data would be that CD8 T cells recognize a cognate
antigen presented by the infected hepatocyte itself, resulting in
killing via a contact-mediated process, e.g., directed secretion of
IFN- or the activity of perforin. However, we cannot formally
exclude the possibility that other cells in the microenvironment—
perhaps traversed hepatocytes or Kupffer cells—present antigen,
provided that they are in close proximity to parasite-infected cells
(12).
Importantly, these experiments were designed to maximize the
possibility of detecting bystander killing. We used large numbers
of parasites in all experiments (1  104 to 1  105), i.e., several
orders of magnitude larger than the number of parasites injected
by an infected mosquito, which is in the range of 1  101 to 1  103
(21–23). Moreover, the use of mice, which have small livers, fur-
ther increased the density of parasite infection. We also used large
numbers of T cells (5  106), giving a dose that was clearly capable
of eliminating all cognate parasites, as seen in the experiments in
which infection was allowed to proceed to the blood stage. Finally,
we primed the T cells by using a recombinant vaccinia virus, a
regimen that has previously been shown to produce a large pro-
portion of polyfunctional effector T cells secreting a range of cy-
tokines and having strong cytolytic activity (24).
Our data are perhaps surprising in the light of previous find-
ings that have suggested that IFN- and TNF- are among the
main effector molecules involved in the elimination of P. berghei
parasites (2, 4–6). Release of these cytokines into the liver might
reasonably be expected to induce bystander killing. In particular,
TNF- has been reported to be secreted multidirectionally follow-
ing the ligation of CD8 T cells, suggesting that it might act on
bystander cells in addition to cognate targets (25). IFN- secretion
has generally been assumed to be synaptic and highly localized,
though multidirectional secretion has also been reported (25–27).
In a recent study, IFN- produced by CD4 T cells was able to
induce bystander killing of Leishmania major parasites in the skin
(28). However, the radius over which bystander killing could oc-
cur was calculated at 80 m, whereas from the imaging experi-
ments shown in Fig. 2, we would estimate the average separation
of bystander parasites to be 300 m when 1  105 parasites are
used for infection. Thus, it may be that infected hepatocytes are
simply not close enough to allow bystander killing to occur. Sur-
prisingly, given that killing occurs locally, previous studies have
shown little or no role for perforin and granzyme in the killing of
P. berghei parasites as used in this study (6, 7). On the other hand,
perforin has been shown to play a role in CD8 T cell killing of P.
yoelii parasites in vitro (29), though with conflicting results in vivo
(6, 30).
An important implication of these data is that elimination of
parasites from the liver by CD8 T cells is dependent upon each
and every parasite being found and eliminated by at least one
cognate CD8 T cell. However, the interaction of a cognate CD8
T cell with antigen can initiate the recruitment of further CD8 T
cells to the region surrounding the infected hepatocyte, which
may increase the likelihood of other parasites being eliminated
(10). Nonetheless, given the large size of the liver and the low
frequency of infected hepatocytes in natural infection, it is per-
haps not surprising that high frequencies of CD8 T cells are
required for sterile protection (31, 32). Overall, these data further
support the notion that robust immunization strategies, perhaps
including the use of prime-boost regimens, will be required for the
induction of protective CD8 T cell responses against liver-stage
malaria parasites (33, 34).
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